Stock Events

Stock Events

Bachem 

$9.91
65
-$0.23-2.22% 14:38 Today

Statistics

Day High
9.69
Day Low
9.69
52W High
12.54
52W Low
5.97
Volume
247
Avg. Volume
1,635
Mkt Cap
742.24M
P/E Ratio
38
Dividend Yield
0.57%
Dividend
0.06

Upcoming

Dividends

0.57%Dividend Yield
May 2026
$0.05
May 2026
$0.06
May 2025
$0.05
May 2025
$0.04
May 2024
$0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
10.69%
1Y Growth
10.29%

Earnings

Jul 30Expected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0.43
0.84
1.25
1.67
Expected EPS
0.57834425
Actual EPS
0.828857

Financials

21.4%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
876.35MRevenue
187.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BCHMY. It's not an investment recommendation.
Bitcoin
15
BTC.CRYPTO
Novartis
15
NOVN.SW
Nestle SA
13
NESN.SW
Alphabet
12
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap249.05B
Amgen is a biotechnology company that competes with Bachem in the development and manufacturing of peptide-based therapeutics.
Lilly(Eli) &
LLY
Mkt Cap1.21T
Eli Lilly is a pharmaceutical company with a strong focus on peptide and protein-based drugs, directly competing with Bachem's peptide synthesis services.
Novo Nordisk
NVO
Mkt Cap177.74B
Novo Nordisk specializes in diabetes care and biopharmaceuticals, including peptide treatments, making it a competitor in the peptide therapeutic market.
Pfizer
PFE
Mkt Cap167.52B
Pfizer is a global pharmaceutical corporation that competes with Bachem in the development and production of peptide and protein-based drugs.
Merck
MRK
Mkt Cap361.73B
Merck is a healthcare company that develops peptide-based therapeutics, competing with Bachem in the biopharmaceutical sector.
Sanofi
SNY
Mkt Cap112.71B
Sanofi is a global pharmaceutical company that develops peptide-based drugs, competing with Bachem in the peptide therapeutics market.
Astrazeneca
AZN
Mkt Cap289.14B
AstraZeneca is a biopharmaceutical company that competes with Bachem in the development of peptide and protein-based therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap127.02B
Bristol Myers Squibb is a global biopharmaceutical company that develops peptide and protein-based drugs, competing with Bachem.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.72B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including peptide-based therapies, competing with Bachem in the generics and specialty drug market.

About

Bachem Holding AG provides essential products to pharmaceutical and biotechnology companies worldwide, supporting their activities from early research and clinical trials through to commercial manufacturing. The company's primary focus is on the development, production, and regulatory assistance for peptide active pharmaceutical ingredients (APIs), particularly novel peptide and oligonucleotide compounds. Additionally, Bachem offers commercial-grade new chemical entities (NCEs) and generic APIs, complemented by services including project management, quality assurance, regulatory guidance, analytical testing, Good Manufacturing Practice (GMP) compliant production, research-grade material manufacturing, and integrated supply chain solutions. Established in 1971, this Swiss company is headquartered in Bubendorf and operates as a subsidiary of Ingro Finanz AG.
Show More
CEO
Anne-Kathrin Stoller
Employees
2511
Country
Switzerland
ISIN
US05636G1058
WKN
000A3D9JM

Listings

SW
CH
BANB.SW
STU
DE
BHM0.STU
MU
DE
BHM0.MU
OTC Link
US
BCHMY

0 Comments

Share your thoughts

FAQs

What is Bachem stock price today?▼
The current price of BCHMY is $9.91 USD — it has decreased by -2.22% in the past 24 hours. Watch Bachem stock price performance more closely on the chart.
What is Bachem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Bachem stocks are traded under the ticker BCHMY.
Is Bachem stock price growing?▼
BCHMY stock has risen by +1.75% compared to the previous week, the month change is a +1.59% rise, over the last year Bachem has showed a +52.27% increase.
What is Bachem market cap?▼
Today Bachem has the market capitalization of 742.24M
When is the next Bachem earnings date?▼
Bachem is going to release the next earnings report on March 4, 2027.
What were Bachem earnings last quarter?▼
BCHMY earnings for the last quarter are 0.83 USD per share, whereas the estimation was 0.58 USD resulting in a +43.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bachem revenue for the last year?▼
Bachem revenue for the last year amounts to 876.35M USD.
What is Bachem net income for the last year?▼
BCHMY net income for the last year is 187.58M USD.
Does Bachem pay dividends?▼
Yes, BCHMY dividends are paid annual. The last dividend per share was 0.05 . As of today, Dividend Yield (FWD)% is 0.57%.
How many employees does Bachem have?▼
As of November 10, 2026, the company has 2,511 employees.
In which sector is Bachem located?▼
Bachem operates in the Health & Wellness sector.
When did Bachem complete a stock split?▼
Bachem has not had any recent stock splits.
Where is Bachem headquartered?▼
Bachem is headquartered in Bubendorf, Switzerland.